Aurinia Pharmaceuticals Inc. Employee Count
The employee counts Aurinia Pharmaceuticals Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 128; Filing 2026-02-26; Lease expense per employee $6,250.00.
- 2024-12-31: Employees (as filed) 130; Filing 2025-02-27; Lease expense per employee $6,153.85.
- 2023-12-31: Employees (as filed) 300; Filing 2024-02-15; Lease expense per employee $2,666.67.
- 2022-12-31: Employees (as filed) 300; Filing 2023-02-28; Lease expense per employee $3,333.33.
- Available history
- 2020-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 128 full-time equivalent | 2026-02-26 | $6,250.00 operating |
| 2024-12-31 | 130 | 2025-02-27 | $6,153.85 operating |
| 2023-12-31 | 300 | 2024-02-15 | $2,666.67 operating |
| 2022-12-31 | 300 | 2023-02-28 | $3,333.33 operating |
| 2021-12-31 | 300 | 2022-02-28 | $4,130.00 total lease cost |
| 2020-12-31 | 294 | 2021-02-24 | $3,210.88 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B |